HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics

Histone deacetylases (HDACs) and histone acetyl transferases (HATs) are two counteracting enzyme families whose enzymatic activity controls the acetylation state of protein lysine residues, notably those contained in the N-terminal extensions of the core histones. Acetylation of histones affects gene expression through its influence on chromatin conformation. In addition, several non-histone proteins are regulated in their stability or biological function by the acetylation state of specific lysine residues. HDACs intervene in a multitude of biological processes and are part of a multiprotein family in which each member has its specialized functions. In addition, HDAC activity is tightly controlled through targeted recruitment, protein-protein interactions and post-translational modifications. Control of cell cycle progression, cell survival and differentiation are among the most important roles of these enzymes. Since these processes are affected by malignant transformation, HDAC inhibitors were developed as antineoplastic drugs and are showing encouraging efficacy in cancer patients.

[1]  R. Eils,et al.  Genome-wide expression screens indicate a global role for protein kinase CK2 in chromatin remodeling , 2003, Journal of Cell Science.

[2]  H. Hess-Stumpp Histone deacetylase inhibitors and cancer: from cell biology to the clinic. , 2005, European journal of cell biology.

[3]  Yewei Liu,et al.  Activity-dependent and -independent nuclear fluxes of HDAC4 mediated by different kinases in adult skeletal muscle , 2005, The Journal of cell biology.

[4]  E. Olson,et al.  Histone Deacetylase 7 Maintains Vascular Integrity by Repressing Matrix Metalloproteinase 10 , 2006, Cell.

[5]  James D. Winkler,et al.  Cloning and Characterization of a Novel Human Class I Histone Deacetylase That Functions as a Transcription Repressor* , 2000, The Journal of Biological Chemistry.

[6]  G. Unger,et al.  Protein kinase CK2 as regulator of cell survival: implications for cancer therapy. , 2004, Current cancer drug targets.

[7]  N. Perkins,et al.  P300 transcriptional repression is mediated by SUMO modification. , 2003, Molecular cell.

[8]  Paul L. Richardson,et al.  α-Keto amides as inhibitors of histone deacetylase , 2003 .

[9]  D. O’Carroll,et al.  Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression , 2002, The EMBO journal.

[10]  T. Tsuruo,et al.  A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Heterocyclic ketones as inhibitors of histone deacetylase. , 2003, Bioorganic & medicinal chemistry letters.

[12]  J. Davie,et al.  The Transcriptional Repressor Sp3 Is Associated with CK2-phosphorylated Histone Deacetylase 2* , 2002, The Journal of Biological Chemistry.

[13]  P. Kwon,et al.  Mammalian histone deacetylase 1 protein is posttranslationally modified by phosphorylation. , 2001, Biochemical and biophysical research communications.

[14]  A. Bird,et al.  Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. , 1999, Genes & development.

[15]  V. Ingram,et al.  n-Butyrate causes histone modification in HeLa and Friend erythroleukaemia cells , 1977, Nature.

[16]  Andreas Schwienhorst,et al.  Members of the histone deacetylase superfamily differ in substrate specificity towards small synthetic substrates. , 2004, Biochemical and biophysical research communications.

[17]  C. Allis,et al.  Histone acetyltransferases. , 2001, Annual review of biochemistry.

[18]  Keith B Glaser,et al.  Trifluoromethyl ketones as inhibitors of histone deacetylase. , 2002, Bioorganic & medicinal chemistry letters.

[19]  R. Evans,et al.  Regulation of MEF2 by Histone Deacetylase 4- and SIRT1 Deacetylase-Mediated Lysine Modifications , 2005, Molecular and Cellular Biology.

[20]  A. V. van Kuilenburg,et al.  Histone deacetylases (HDACs): characterization of the classical HDAC family. , 2003, The Biochemical journal.

[21]  R. De Francesco,et al.  Crystal structure of a eukaryotic zinc-dependent histone deacetylase, human HDAC8, complexed with a hydroxamic acid inhibitor. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[22]  C. Van Lint,et al.  The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation. , 1996, Gene expression.

[23]  G. Perez,et al.  Intrinsic apoptotic and thioredoxin pathways in human prostate cancer cell response to histone deacetylase inhibitor , 2006, Proceedings of the National Academy of Sciences.

[24]  Victor G Corces,et al.  Phosphorylation of histone H3: a balancing act between chromosome condensation and transcriptional activation. , 2004, Trends in genetics : TIG.

[25]  S. Schreiber,et al.  CoREST is an integral component of the CoREST- human histone deacetylase complex. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[26]  Andrew J. Bannister,et al.  Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain , 2001, Nature.

[27]  Rick B. Vega,et al.  Regulation of Cardiac Stress Signaling by Protein Kinase D1 , 2006, Molecular and Cellular Biology.

[28]  Ping Zhu,et al.  Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis. , 2004, Cancer cell.

[29]  F. Dequiedt,et al.  Phosphorylation of histone deacetylase 7 by protein kinase D mediates T cell receptor–induced Nur77 expression and apoptosis , 2005, The Journal of experimental medicine.

[30]  E. Olson,et al.  Histone Deacetylases 5 and 9 Govern Responsiveness of the Heart to a Subset of Stress Signals and Play Redundant Roles in Heart Development , 2004, Molecular and Cellular Biology.

[31]  Eric Verdin,et al.  Histone deacetylase HDAC8 associates with smooth muscle α‐actin and is essential for smooth muscle cell contractility , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  J. Yates,et al.  Attenuation of a phosphorylation-dependent activator by an HDAC–PP1 complex , 2003, Nature Structural Biology.

[33]  J. R. Somoza,et al.  Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases. , 2004, Structure.

[34]  P. Spellman,et al.  The SIN3 Deacetylase Complex Represses Genes Encoding Mitochondrial Proteins , 2003, Journal of Biological Chemistry.

[35]  Brian T Chait,et al.  The N-CoR-HDAC3 nuclear receptor corepressor complex inhibits the JNK pathway through the integral subunit GPS2. , 2002, Molecular cell.

[36]  A. Means,et al.  The Modular Nature of Histone Deacetylase HDAC4 Confers Phosphorylation-dependent Intracellular Trafficking* , 2001, The Journal of Biological Chemistry.

[37]  S. Westerheide,et al.  Tumor Necrosis Factor α-induced Phosphorylation of RelA/p65 on Ser529 Is Controlled by Casein Kinase II* , 2000, The Journal of Biological Chemistry.

[38]  C. Allis,et al.  Modulation of histone acetylation by [4-(acetylamino)-N-(2-amino-phenyl) benzamide] in HCT-8 colon carcinoma. , 2003, Molecular cancer therapeutics.

[39]  Xiang-Jiao Yang,et al.  Class II Histone Deacetylases: from Sequence to Function, Regulation, and Clinical Implication , 2005, Molecular and Cellular Biology.

[40]  Cyrus Martin,et al.  The diverse functions of histone lysine methylation , 2005, Nature Reviews Molecular Cell Biology.

[41]  D. Christianson Arginase: structure, mechanism, and physiological role in male and female sexual arousal. , 2005, Accounts of chemical research.

[42]  E. Seto,et al.  Regulation of Histone Deacetylase 2 by Protein Kinase CK2* , 2002, The Journal of Biological Chemistry.

[43]  L. Laimins,et al.  Histone deacetylase 3 localizes to the plasma membrane and is a substrate of Src , 2006, Oncogene.

[44]  R A Rifkind,et al.  Second generation hybrid polar compounds are potent inducers of transformed cell differentiation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[45]  Y. E. Chin,et al.  Stat3 Dimerization Regulated by Reversible Acetylation of a Single Lysine Residue , 2005, Science.

[46]  N. Amariglio,et al.  The nuclear-envelope protein and transcriptional repressor LAP2β interacts with HDAC3 at the nuclear periphery, and induces histone H4 deacetylation , 2005, Journal of Cell Science.

[47]  S. Horinouchi,et al.  In vivo destabilization of dynamic microtubules by HDAC6‐mediated deacetylation , 2002, The EMBO journal.

[48]  J. Ausió,et al.  Histone ubiquitination: a tagging tail unfolds? , 2002, BioEssays : news and reviews in molecular, cellular and developmental biology.

[49]  T. Tsang,et al.  Differential gene expression profiling of CD34+ CD133+ umbilical cord blood hematopoietic stem progenitor cells. , 2005, Stem cells and development.

[50]  E. Olson,et al.  Activation of the myocyte enhancer factor-2 transcription factor by calcium/calmodulin-dependent protein kinase-stimulated binding of 14-3-3 to histone deacetylase 5. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[51]  Minoru Yoshida,et al.  FK228 (depsipeptide) as a natural prodrug that inhibits class I histone deacetylases. , 2002, Cancer research.

[52]  Jerry L. Workman,et al.  Sds3 (Suppressor of Defective Silencing 3) Is an Integral Component of the Yeast Sin3·Rpd3 Histone Deacetylase Complex and Is Required for Histone Deacetylase Activity* , 2000, The Journal of Biological Chemistry.

[53]  P. Atadja,et al.  Isolation and Characterization of a Novel Class II Histone Deacetylase, HDAC10* , 2002, The Journal of Biological Chemistry.

[54]  R. Cortese,et al.  Dissecting the Biological Functions of Drosophila Histone Deacetylases by RNA Interference and Transcriptional Profiling* , 2006, Journal of Biological Chemistry.

[55]  E. Seto,et al.  Negative Regulation of Histone Deacetylase 8 Activity by Cyclic AMP-Dependent Protein Kinase A , 2004, Molecular and Cellular Biology.

[56]  G. Zlokarnik,et al.  Quantitation of transcription and clonal selection of single living cells with beta-lactamase as reporter. , 1998, Science.

[57]  A. Ravid,et al.  Effect of polar organic compounds on leukemic cells: Butyrate‐induced partial remission of acute myelogenous leukemia in a child , 1983, Cancer.

[58]  Matthew H. Brush,et al.  Deactylase Inhibitors Disrupt Cellular Complexes Containing Protein Phosphatases and Deacetylases* , 2004, Journal of Biological Chemistry.

[59]  A. Sharrocks,et al.  SUMO promotes HDAC-mediated transcriptional repression. , 2004, Molecular cell.

[60]  E. Seto,et al.  Histone deacetylase 3 (HDAC3) activity is regulated by interaction with protein serine/threonine phosphatase 4. , 2005, Genes & development.

[61]  D M Schmatz,et al.  Apicidin: a novel antiprotozoal agent that inhibits parasite histone deacetylase. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[62]  A. Hauschild,et al.  A phase II multicenter study on the histone deacetylase (HDAC) inhibitor MS-275, comparing two dosage schedules in metastatic melanoma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[63]  D. Sterner,et al.  Histone modifications: Now summoning sumoylation , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[64]  S. Schreiber,et al.  Histone Deacetylase 1 Phosphorylation Promotes Enzymatic Activity and Complex Formation* , 2001, The Journal of Biological Chemistry.

[65]  Chun Li Zhang,et al.  Class II Histone Deacetylases Act as Signal-Responsive Repressors of Cardiac Hypertrophy , 2002, Cell.

[66]  Rick B. Vega,et al.  Protein Kinases C and D Mediate Agonist-Dependent Cardiac Hypertrophy through Nuclear Export of Histone Deacetylase 5 , 2004, Molecular and Cellular Biology.

[67]  B. Schultz,et al.  Kinetics and comparative reactivity of human class I and class IIb histone deacetylases. , 2004, Biochemistry.

[68]  R. Ficner,et al.  Crystal structure of a bacterial class 2 histone deacetylase homologue. , 2005, Journal of molecular biology.

[69]  小澤 幸泰 Histone deacetylase 3 associates with and represses the transcription factor GATA-2 , 2001 .

[70]  Karl Mechtler,et al.  Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins , 2001, Nature.

[71]  Marie Joseph,et al.  Transcriptional signature of histone deacetylase inhibition in multiple myeloma: biological and clinical implications. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[72]  E. Seto,et al.  The orphan nuclear receptor TR2 interacts directly with both class I and class II histone deacetylases. , 2001, Molecular endocrinology.

[73]  Julia Tischler,et al.  The Tumor Suppressor p53 and Histone Deacetylase 1 Are Antagonistic Regulators of the Cyclin-Dependent Kinase Inhibitor p21/WAF1/CIP1 Gene , 2003, Molecular and Cellular Biology.

[74]  S. Whittaker,et al.  International multicenter phase II study of the HDAC inhibitor (HDACi) depsipeptide (FK228) in cutaneous T-cell lymphoma (CTCL): Interim report. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[75]  A. Mirsky,et al.  ACETYLATION AND METHYLATION OF HISTONES AND THEIR POSSIBLE ROLE IN THE REGULATION OF RNA SYNTHESIS. , 1964, Proceedings of the National Academy of Sciences of the United States of America.

[76]  B. Garcia,et al.  A novel histone deacetylase pathway regulates mitosis by modulating Aurora B kinase activity. , 2006, Genes & development.

[77]  O. Medalia,et al.  Protein kinase CK2 and protein kinase D are associated with the COP9 signalosome , 2003, The EMBO journal.

[78]  M. Guenther,et al.  The SMRT and N-CoR Corepressors Are Activating Cofactors for Histone Deacetylase 3 , 2001, Molecular and Cellular Biology.

[79]  Eric Verdin,et al.  Duration of Nuclear NF-κB Action Regulated by Reversible Acetylation , 2001, Science.

[80]  Xiao-Fan Wang,et al.  HDAC6 is a microtubule-associated deacetylase , 2002, Nature.

[81]  Guangjin Li,et al.  Identification of histone deacetylase-3 domains that interact with the orphan nuclear receptor TR2. , 2003, Biochemical and biophysical research communications.

[82]  L. Pinna,et al.  One‐thousand‐and‐one substrates of protein kinase CK2? , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[83]  T. Jenuwein,et al.  The many faces of histone lysine methylation. , 2002, Current opinion in cell biology.

[84]  B. Vallee,et al.  Active-site zinc ligands and activated H2O of zinc enzymes. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[85]  Minoru Yoshida,et al.  [Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A]. , 1990, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.

[86]  R. Schwartz,et al.  Calcium/Calmodulin-dependent Protein Kinase Activates Serum Response Factor Transcription Activity by Its Dissociation from Histone Deacetylase, HDAC4 , 2003, Journal of Biological Chemistry.

[87]  R. Huguenin,et al.  Isolierung und Strukturaufklärung von Chlamydocin , 1974 .

[88]  E. Miska,et al.  The SUMO E3 ligase RanBP2 promotes modification of the HDAC4 deacetylase , 2002, The EMBO journal.

[89]  S. Haggarty,et al.  Multidimensional chemical genetic analysis of diversity-oriented synthesis-derived deacetylase inhibitors using cell-based assays. , 2003, Chemistry & biology.

[90]  P. Leder,et al.  Butyric acid, a potent inducer of erythroid differentiation in cultured erythroleukemic cells , 1975, Cell.

[91]  K. Ahmed,et al.  Dynamics of Protein Kinase CK2 Association with Nucleosomes in Relation to Transcriptional Activity* , 1998, The Journal of Biological Chemistry.

[92]  C. Allis,et al.  Translating the Histone Code , 2001, Science.

[93]  V. Kiermer,et al.  HDAC7, a thymus-specific class II histone deacetylase, regulates Nur77 transcription and TCR-mediated apoptosis. , 2003, Immunity.

[94]  Z. Cao,et al.  CRA-024781: a novel synthetic inhibitor of histone deacetylase enzymes with antitumor activity in vitro and in vivo , 2006, Molecular Cancer Therapeutics.

[95]  Nicola J. Rinaldi,et al.  Global position and recruitment of HATs and HDACs in the yeast genome. , 2004, Molecular cell.

[96]  S. Schreiber,et al.  Genomewide studies of histone deacetylase function in yeast. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[97]  C. Sardet,et al.  Post-activation Turn-off of NF-κB-dependent Transcription Is Regulated by Acetylation of p65* , 2003, The Journal of Biological Chemistry.

[98]  T. Kummalue,et al.  The inv(16) Fusion Protein Associates with Corepressors via a Smooth Muscle Myosin Heavy-Chain Domain , 2003, Molecular and Cellular Biology.

[99]  P. Finn,et al.  Pharmacodynamic response and inhibition of growth of human tumor xenografts by the novel histone deacetylase inhibitor PXD101. , 2003, Molecular cancer therapeutics.

[100]  Xiang-Jiao Yang,et al.  Lysine acetylation and the bromodomain: a new partnership for signaling , 2004, BioEssays : news and reviews in molecular, cellular and developmental biology.

[101]  A. Nudelman,et al.  Prodrugs of butyric acid from bench to bedside: Synthetic design, mechanisms of action, and clinical applications , 2000 .

[102]  R. B. Pringle Chemical constitution of the host-specific toxin of Helminthosporium carbonum. , 1970, Plant physiology.

[103]  A. Wozniak,et al.  Chronic Oral Administration of CI-994: A Phase I Study , 2004, Investigational New Drugs.

[104]  M. Lazar,et al.  The histone‐binding code of nuclear receptor co‐repressors matches the substrate specificity of histone deacetylase 3 , 2005, EMBO reports.

[105]  Minoru Yoshida,et al.  HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor. , 2005, Molecular cell.

[106]  Saeed Tavazoie,et al.  Genome-wide binding map of the histone deacetylase Rpd3 in yeast , 2002, Nature Genetics.

[107]  S. Grant,et al.  Histone deacetylase inhibitors: insights into mechanisms of lethality , 2005, Expert opinion on therapeutic targets.

[108]  E. Olson,et al.  Identification of a Signal-Responsive Nuclear Export Sequence in Class II Histone Deacetylases , 2001, Molecular and Cellular Biology.

[109]  H. Itazaki,et al.  Isolation and structural elucidation of new cyclotetrapeptides, trapoxins A and B, having detransformation activities as antitumor agents. , 1990, The Journal of antibiotics.

[110]  L. Ngo,et al.  Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[111]  Michael Rowley,et al.  A series of novel, potent, and selective histone deacetylase inhibitors. , 2006, Bioorganic & medicinal chemistry letters.

[112]  Jacques Côté,et al.  The diverse functions of histone acetyltransferase complexes. , 2003, Trends in genetics : TIG.

[113]  Ping-Hui Tseng,et al.  Histone Acetylation-independent Effect of Histone Deacetylase Inhibitors on Akt through the Reshuffling of Protein Phosphatase 1 Complexes* , 2005, Journal of Biological Chemistry.

[114]  James Bradner,et al.  Inhibition of Histone Deacetylase 6 Acetylates and Disrupts the Chaperone Function of Heat Shock Protein 90 , 2005, Journal of Biological Chemistry.

[115]  Robert Brown,et al.  A phase 1 pharmacokinetic (PK) and pharmacodynamic (PD) study of the histone deacetylase (HDAC) inhibitor PXD101 in patients (pts) with advanced solid tumours , 2005 .

[116]  M. Yoshida,et al.  Trapoxin, an antitumor cyclic tetrapeptide, is an irreversible inhibitor of mammalian histone deacetylase. , 1993, The Journal of biological chemistry.

[117]  Xiang-Jiao Yang,et al.  Association with Class IIa Histone Deacetylases Upregulates the Sumoylation of MEF2 Transcription Factors , 2005, Molecular and Cellular Biology.

[118]  Brian D. Strahl,et al.  Role of Histone H3 Lysine 9 Methylation in Epigenetic Control of Heterochromatin Assembly , 2001, Science.

[119]  司履生 Cancer epigenetics , 2006 .

[120]  Michael Grunstein,et al.  Requirement of Hos2 Histone Deacetylase for Gene Activity in Yeast , 2002, Science.

[121]  E. Seto,et al.  Collaborative spirit of histone deacetylases in regulating chromatin structure and gene expression. , 2003, Current opinion in genetics & development.

[122]  Stuart L Schreiber,et al.  Histone Deacetylase Activity Is Required for Full Transcriptional Repression by mSin3A , 1997, Cell.

[123]  P. Atadja,et al.  N-hydroxy-3-phenyl-2-propenamides as novel inhibitors of human histone deacetylase with in vivo antitumor activity: discovery of (2E)-N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2-propenamide (NVP-LAQ824). , 2003, Journal of medicinal chemistry.

[124]  R. DePinho,et al.  SUMO-1 Modification of Histone Deacetylase 1 (HDAC1) Modulates Its Biological Activities* , 2002, The Journal of Biological Chemistry.

[125]  Stuart L Schreiber,et al.  Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[126]  J. Vance,et al.  The Deacetylase HDAC6 Regulates Aggresome Formation and Cell Viability in Response to Misfolded Protein Stress , 2003, Cell.

[127]  G. Draetta,et al.  The adenovirus protein Gam1 interferes with sumoylation of histone deacetylase 1 , 2002, EMBO reports.

[128]  Anthony P. Davis,et al.  Nanotechnology: Synthetic molecular motors , 1999, Nature.

[129]  Yong-Sik Kim,et al.  Krüppel-like zinc finger protein Gli-similar 2 (Glis2) represses transcription through interaction with C-terminal binding protein 1 (CtBP1) , 2005, Nucleic acids research.

[130]  E. Seto,et al.  Acetylation and deacetylation of non-histone proteins. , 2005, Gene.

[131]  Ioannis Xenarios,et al.  Microarray Deacetylation Maps Determine Genome-Wide Functions for Yeast Histone Deacetylases , 2002, Cell.

[132]  L. Schwartz,et al.  Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[133]  T. Yao,et al.  Intracellular Trafficking of Histone Deacetylase 4 Regulates Neuronal Cell Death , 2005, The Journal of Neuroscience.

[134]  K. Robertson DNA methylation and human disease , 2005, Nature Reviews Genetics.

[135]  P. Marks,et al.  Drug Insight: histone deacetylase inhibitors—development of the new targeted anticancer agent suberoylanilide hydroxamic acid , 2005, Nature Clinical Practice Oncology.

[136]  K. Resing,et al.  Phosphatase Inhibition Leads to Histone Deacetylases 1 and 2 Phosphorylation and Disruption of Corepressor Interactions* , 2002, The Journal of Biological Chemistry.

[137]  L. Guarente,et al.  The Sir2 family of protein deacetylases. , 2004, Annual review of biochemistry.

[138]  R. DePinho,et al.  Identification of Mammalian Sds3 as an Integral Component of the Sin3/Histone Deacetylase Corepressor Complex , 2002, Molecular and Cellular Biology.

[139]  J. McNally,et al.  Modification of de novo DNA methyltransferase 3a (Dnmt3a) by SUMO-1 modulates its interaction with histone deacetylases (HDACs) and its capacity to repress transcription. , 2004, Nucleic acids research.

[140]  L. Neckers,et al.  Modulation of p53, ErbB1, ErbB2, and Raf-1 expression in lung cancer cells by depsipeptide FR901228. , 2002, Journal of the National Cancer Institute.

[141]  K. Nagashima,et al.  A new antifungal antibiotic, trichostatin. , 1976, The Journal of antibiotics.

[142]  Lin Li,et al.  Measurement of histone acetyltransferase and histone deacetylase activities and kinetics of histone acetylation. , 2003, Methods.

[143]  E. Olson,et al.  Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation , 2000, Nature.

[144]  S. Minucci,et al.  Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer , 2006, Nature Reviews Cancer.

[145]  E. Seto,et al.  Regulation of histone deacetylase activities , 2004, Journal of cellular biochemistry.

[146]  F. Dequiedt,et al.  Class II histone deacetylases: versatile regulators. , 2003, Trends in genetics : TIG.

[147]  Julia Tischler,et al.  Negative and Positive Regulation of Gene Expression by Mouse Histone Deacetylase1 , 2006, Molecular and Cellular Biology.

[148]  H. Cedar,et al.  Silence of the genes — mechanisms of long-term repression , 2005, Nature Reviews Genetics.

[149]  Chuan-hai Guo,et al.  Role of protein kinase CK2 in phosphorylation of nucleosomal proteins in relation to transcriptional activity , 2004, Molecular and Cellular Biochemistry.

[150]  Andrew J. Wilson,et al.  Histone Deacetylase 3 (HDAC3) and Other Class I HDACs Regulate Colon Cell Maturation and p21 Expression and Are Deregulated in Human Colon Cancer* , 2006, Journal of Biological Chemistry.

[151]  S. Friedman,et al.  Krüppel-like Factor-6 Promotes Preadipocyte Differentiation through Histone Deacetylase 3-dependent Repression of DLK1* , 2005, Journal of Biological Chemistry.

[152]  K. Glaser,et al.  Expression and functional characterization of recombinant human HDAC1 and HDAC3. , 2004, Life sciences.

[153]  Fred Asselbergs,et al.  Cloning and Functional Characterization of HDAC11, a Novel Member of the Human Histone Deacetylase Family* , 2002, The Journal of Biological Chemistry.

[154]  V. Giguère,et al.  Control of MEF2 Transcriptional Activity by Coordinated Phosphorylation and Sumoylation* , 2006, Journal of Biological Chemistry.

[155]  T. Kuzel,et al.  Vorinostat (suberoylanilide hydroxamic acid, SAHA) is clinically active in advanced cutaneous T-cell lymphoma (CTCL): Results of a phase IIb trial. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[156]  K. Kristiansen,et al.  The retinoblastoma-histone deacetylase 3 complex inhibits PPARgamma and adipocyte differentiation. , 2002, Developmental cell.

[157]  Prim B. Singh,et al.  Mammalian chromodomain proteins: their role in genome organisation and expression. , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.

[158]  E. Seto,et al.  Histone Deacetylase 8 Safeguards the Human Ever-Shorter Telomeres 1B (hEST1B) Protein from Ubiquitin-Mediated Degradation , 2006, Molecular and Cellular Biology.

[159]  P. Marks,et al.  Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors , 1999, Nature.

[160]  M. Privalsky,et al.  The SMRT corepressor is a target of phosphorylation by protein kinase CK2 (casein kinase II) , 2001, Molecular and Cellular Biochemistry.

[161]  Wen‐Ming Yang,et al.  Functional Domains of Histone Deacetylase-3* , 2002, The Journal of Biological Chemistry.

[162]  John M. Shelton,et al.  Histone Deacetylase 4 Controls Chondrocyte Hypertrophy during Skeletogenesis , 2004, Cell.